{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:39:58Z","timestamp":1761964798084},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.semnephrol.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T06:31:05Z","timestamp":1477031465000},"page":"362-371","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oncogenic \u03b3 Herpesviruses EBV and HHV8 in Kidney Transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Jade","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.05.013_bib1","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":"Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.32.2.458-467.1979","article-title":"Polypeptides of the Epstein-Barr virus membrane antigen complex","volume":"32","author":"Thorley-Lawson","year":"1979","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcv.2006.03.004","article-title":"and Epstein-Barr virus subtypes--the search for clinical significance","volume":"36","author":"Puchhammer-Stockl","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib4","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/JVI.64.9.4549-4552.1990","article-title":"Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos","volume":"64","author":"Flemington","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1086\/510854","article-title":"A study of risk factors for acquisition of Epstein-Barr virus and its subtypes","volume":"195","author":"Higgins","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","article-title":"Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students","volume":"207","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib7","doi-asserted-by":"crossref","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib8","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib9","doi-asserted-by":"crossref","first-page":"150835","DOI":"10.1155\/2013\/150835","article-title":"Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?","volume":"2013","author":"Morscio","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib11","first-page":"147","article-title":"Occurrence of cancers in immunosuppressed organ transplant recipients","author":"Penn","year":"1998","journal-title":"Clin Transpl"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib12","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10428190400012011","article-title":"Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era","volume":"46","author":"Ghobrial","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.tp.0000188687.18972.a8","article-title":"Risk of lymphoma after renal transplantation varies with time: an analysis of the United States Renal Data System","volume":"81","author":"Smith","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib15","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/clinids\/20.5.1346","article-title":"Pretransplantation assessment of the risk of lymphoproliferative disorder","volume":"20","author":"Walker","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zealand","volume":"80","author":"Faull","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00007890-200201270-00020","article-title":"Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation","volume":"73","author":"Petit","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1034\/j.1600-6143.2002.21019.x","article-title":"Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk","volume":"2","author":"Dharnidharka","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib20","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.ajkd.2011.07.015","article-title":"Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses","volume":"58","author":"Kasiske","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.TP.0000100826.58738.2B","article-title":"Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation","volume":"76","author":"Cherikh","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib24","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1111\/j.1600-6143.2007.01845.x","article-title":"A phase I\/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib25","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1600-6143.2007.01972.x","article-title":"Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab","volume":"7","author":"Kirk","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib26","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/01.tp.0000169035.10572.c6","article-title":"Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil","volume":"80","author":"Funch","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","article-title":"Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids","volume":"8","author":"McDonald","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/TP.0b013e3182200e8a","article-title":"Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation","volume":"92","author":"Nee","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib29","first-page":"173","article-title":"The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib30","series-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib31","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00007890-200003150-00023","article-title":"Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation","volume":"69","author":"Kew","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","article-title":"Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience","volume":"5","author":"Trofe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/ajt.12009","article-title":"Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences","volume":"13","author":"Bamoulid","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib35","first-page":"49","article-title":"Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation","volume":"4","author":"Lunardi","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib36","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1111\/ctr.12139","article-title":"Epstein-Barr virus-associated smooth muscle tumors after kidney transplantation: treatment and outcomes in a single center","volume":"27","author":"Tan","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12882-015-0096-3","article-title":"Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report","volume":"16","author":"Hamilton","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib38","first-page":"876301","article-title":"Virus-associated hemophagocytic syndrome in renal transplant recipients: report of 2 cases from a single center","volume":"2015","author":"Nanmoku","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib39","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1399-0012.2005.00388.x","article-title":"Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder","volume":"19","author":"Tsai","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib40","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/ctr.12473","article-title":"Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards","volume":"28","author":"Rychert","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1399-0012.2012.01608.x","article-title":"Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder","volume":"26","author":"Holman","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1309\/AJCP9WYEXKOL9YUV","article-title":"Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders","volume":"141","author":"Cho","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib43","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood.V92.10.3977","article-title":"Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease","volume":"92","author":"Lucas","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":"Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib45","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib46","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1053\/j.ajkd.2006.01.029","article-title":"Sirolimus-induced remission of posttransplantation lymphoproliferative disorder","volume":"47","author":"Cullis","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/TP.0b013e31823ae7db","article-title":"Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"93","author":"Sampaio","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib48","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1432-2277.2012.01485.x","article-title":"(Val-)ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation","volume":"25","author":"Hocker","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib49","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/j.1600-6143.2005.01115.x","article-title":"Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients","volume":"5","author":"Funch","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib50","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib51","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/01.tp.0000202724.07714.a2","article-title":"A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder","volume":"81","author":"Humar","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib52","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(07)70040-2","article-title":"Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis","volume":"8","author":"Opelz","year":"2007","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2016.05.013_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib54","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1600-6143.2011.03478.x","article-title":"Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients","volume":"11","author":"Martin","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00277-007-0298-2","article-title":"Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution","volume":"86","author":"Choquet","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib56","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib57","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11864-011-0177-x","article-title":"Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations","volume":"13","author":"Jagadeesh","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-642-38965-8_10","article-title":"Prevention and treatment for Epstein-Barr virus infection and related cancers","volume":"193","author":"Smets","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib60","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.ajkd.2009.09.026","article-title":"Posttransplant lymphoproliferative disorder following kidney transplant","volume":"55","author":"Morgans","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib62","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1600-6143.2006.01543.x","article-title":"Retransplantation after post-transplant lymphoproliferative disorders: an OPTN\/UNOS database analysis","volume":"6","author":"Johnson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib63","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder (bigstar)","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccm.2005.06.014","article-title":"Post-transplant lymphoproliferative disorder","volume":"26","author":"Loren","year":"2005","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1600-6143.2005.01211.x","article-title":"Treatment of PTLD with rituximab or chemotherapy","volume":"6","author":"Elstrom","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib66","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000079253.06061.52","article-title":"Primary brain lymphomas after kidney transplantation: presentation and outcome","volume":"76","author":"Snanoudj","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib67","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0002-9440(10)65069-9","article-title":"Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells","volume":"156","author":"Mercader","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib68","first-page":"3735","article-title":"Disseminated Kaposi\u2019s sarcoma--full regression after withdrawal of immunosuppressive therapy: report of a case","volume":"19","author":"Wijnveen","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib69","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1357-4310(97)01116-7","article-title":"Aetiology of Kaposi\u2019s sarcoma: current understanding and implications for therapy","volume":"3","author":"Boshoff","year":"1997","journal-title":"Mol Med Today"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib70","first-page":"1222","article-title":"Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance","volume":"9","author":"Broccolo","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib71","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200011093431905","article-title":"Bone marrow failure associated with human herpesvirus 8 infection after transplantation","volume":"343","author":"Luppi","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib72","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1086\/314514","article-title":"Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids","volume":"178","author":"LaDuca","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib73","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/00002030-200308150-00001","article-title":"Human herpesvirus 8 epidemiology: what we do and do not know","volume":"17","author":"Dukers","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib74","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199709150-00001","article-title":"Kaposi\u2019s sarcoma in transplant recipients","volume":"64","author":"Penn","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0002-9343(88)90418-4","article-title":"Kaposi\u2019s sarcoma: the most common tumor after renal transplantation in Saudi Arabia","volume":"84","author":"Qunibi","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib76","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1002\/ijc.22233","article-title":"Kaposi\u2019s sarcoma risk among transplant recipients in the United States (1993-2003)","volume":"119","author":"Mbulaiteye","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9343(79)90731-9","article-title":"Kaposi\u2019s sarcoma in recipients of renal transplants","volume":"67","author":"Harwood","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00007890-199802270-00024","article-title":"Serologic association of human herpesvirus eight with posttransplant Kaposi\u2019s sarcoma in Saudi Arabia","volume":"65","author":"Qunibi","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib79","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/00007890-200005150-00008","article-title":"Outcome of kidney transplant recipients with previous human herpesvirus-8 infection","volume":"69","author":"Frances","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib80","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients","volume":"339","author":"Regamey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib81","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2141.1997.d01-2040.x","article-title":"Human herpesvirus-8\/Kaposi\u2019s sarcoma-associated herpesvirus in organ transplant patients with immunosuppression","volume":"96","author":"Alkan","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib82","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nm862","article-title":"Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors","volume":"9","author":"Barozzi","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib83","first-page":"339","article-title":"Kaposi\u2019s sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France","volume":"2","author":"Farge","year":"1993","journal-title":"Eur J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib84","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/infdis\/jiq092","article-title":"Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda","volume":"203","author":"Butler","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib85","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/S0041-1345(01)02577-5","article-title":"Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry","volume":"33","author":"Woodle","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib86","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u2019s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib87","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","article-title":"Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009","volume":"49","author":"Piselli","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib88","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0272-6386(88)80142-2","article-title":"Kaposi\u2019s sarcoma in cyclosporine-induced gingival hyperplasia","volume":"11","author":"Qunibi","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib89","first-page":"775","article-title":"Kaposi\u2019s sarcoma after renal transplantation","volume":"20","author":"Abbaszadeh","year":"2009","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib90","first-page":"285","article-title":"[Primary effusion lymphoma in two kidney transplant recipients]","volume":"137","author":"Regnier-Rosencher","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib91","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1034\/j.1399-0012.2003.00098.x","article-title":"Human herpesvirus 8 and Epstein-Barr virus-related monotypic large B-cell lymphoproliferative disorder coexisting with mixed variant of Castleman\u2019s disease in a lymph node of a renal transplant recipient","volume":"17","author":"Theate","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib92","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trre.2008.05.004","article-title":"Kaposi sarcoma in transplantation","volume":"22","author":"Lebbe","year":"2008","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib93","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1086\/341088","article-title":"Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma","volume":"186","author":"Pellet","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib94","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jmv.10217","article-title":"Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi\u2019s sarcoma and multicentric Castleman\u2019s disease","volume":"68","author":"Boivin","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/1096-9071(200012)62:4<498::AID-JMV15>3.0.CO;2-B","article-title":"Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study","volume":"62","author":"Enbom","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000184900","article-title":"Posttransplant Kaposi sarcoma: staging as a guide to therapy and prognosis","volume":"48","author":"Al-Khader","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib97","first-page":"83","article-title":"Staging of classic Kaposi\u2019s sarcoma: a useful tool for therapeutic choices","volume":"13","author":"Brambilla","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib98","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1128\/AAC.41.12.2754","article-title":"Antiviral drug susceptibility of human herpesvirus 8","volume":"41","author":"Neyts","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib99","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00007890-199608270-00007","article-title":"Renal transplantation exposes patients with previous Kaposi\u2019s sarcoma to a high risk of recurrence","volume":"62","author":"Doutrelepont","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2016.05.013_bib100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00007890-200201270-00025","article-title":"No recurrence of posttransplantation Kaposi\u2019s sarcoma three years after renal retransplantation","volume":"73","author":"Euvrard","year":"2002","journal-title":"Transplantation"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516300444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T20:56:08Z","timestamp":1601153768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516300444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0270929516300444"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.013","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogenic \u03b3 Herpesviruses EBV and HHV8 in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}